The activity of thymidine phosphorylase as a new ovarian tumor marker

Gynecologic Oncology

Volumn 94, Issue 1, 2004, Pages 86-92

  Miszczak Zaborska, Elzbieta ^a   Wójcik Krowiranda, Katarzyna ^a   Kubiak, Robert ^a   Bieńkiewicz, Andrzej ^a   Bartkowiak, Jacek ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Microvessel count; Ovarian cancer; PD ECGF; Platelet derived endothelial cell growth factor; Thymidine phosphorylase

Indexed keywords

BIOLOGICAL MARKER; THYMIDINE PHOSPHORYLASE;

ADULT; AGED; ANGIOGENESIS; ARTICLE; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC VALUE; DISEASE MARKER; DISEASE SEVERITY; ENZYME ACTIVITY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MICROVASCULATURE; OVARY CANCER; OVARY TUMOR; PRIORITY JOURNAL; SPECTROPHOTOMETRY; STATISTICAL SIGNIFICANCE; SURFACE PROPERTY; TUMOR CELL;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM STAGING; NEOVASCULARIZATION, PATHOLOGIC; OVARIAN NEOPLASMS; THYMIDINE PHOSPHORYLASE; TUMOR MARKERS, BIOLOGICAL;

EID: 3242735926     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ygyno.2004.04.011     Document Type: Article

References (44)

1. Folkman J. Tumour angiogenesis, therapeutic implications. N. Engl. J. Med. 285:1971;1182-1186
2. Hollingsworth B., Parkin D. The efficiency of Scottish acute hospitals: an application of data envelopment analysis. IMA J. Math. Appl. Med. Biol. 12:1995;161-173
3. Reynolds K., Farzaneh F., Collins W.P., Campbell S., Bourne T.H., Lawton F., et al. Association of ovarian malignancy with expression of platelet-derived endothelial cell growth factor. J. Natl. Cancer Inst. 86:1994;1234-1238
4. Barton G.J., Ponting C.P., Spraggon G., Finnis C., Sleep D. Human platelet-derived endothelial cell growth factor is homologous to Escherichia coli thymidine phosphorylase. Protein Sci. 1:1992;688-690
5. Sumizawa T., Furukawa M., Haraguchi A., Yoshimura A., Takeyasu M., Ishizawa Y., et al. Thymidine phosphorylase activity associated with platelet-derived endothelial cell growth factor. J. Biochem. 114:1993;9-14
6. Moghaddam A., Bicknell R. Expression of platelet-derived endothelial cell growth factor in Escherichia coli and confirmation of its thymidine phosphorylase activity. Biochemistry. 31:1992;12141-12146
7. Usuki K., Gonez L.J., Wernstedt C., Moren A., Miyazono K., Claesson-Welsh L., et al. Structural properties of 3.0 kb and 3.2 kb transcripts encoding platelet-derived endothelial cell growth factor/thymidine phosphorylase in A431 cells. Biochim. Biophys. Acta. 1222:1994;411-414
8. Haraguchi M., Miyadera K., Uemura K., Sumizawa T., Furukawa T., Yamada K., et al. Angiogenic activity of enzyme. Nature. 368:1994;198
9. Streeter E.H., Harris A.L. Angiogenesis in bladder cancer - Prognostic marker and target for future therapy. Surg. Oncol. 11:2002;85-100
10. Tsukagoshi S., Saga Y., Suzuki N., Fujioka A., Nakagawa F., Fukushima M., et al. Thymidine phosphorylase-mediated angiogenesis regulated by thymidine phosphorylase inhibitor in human ovarian cancer cells in vivo. Int. J. Oncol. 22:2003;961-967
11. Hata K., Fujiwaki R., Nakayama K., Maede Y., Fukumoto M., Miyazaki K. Expression of thymidine phosphorylase and vascular endothelial growth factor in epithelial ovarian cancer: correlation with angiogenesis and progression of the tumor. Anticancer Res. 20:2000;3941-3949
12. Kondo S., Asano M., Matsuo K., Ohmori I., Suzuki H. Vascular endothelial growth factor/vascular permeability factor is detectable in the sera of tumor-bearing mice and cancer patients. Biochim. Biophys. Acta. 1221:1994;211-214
13. Yamamoto Y., Toi M., Kondo S., Matsumoto T., Suzuki H., Kitamura M., et al. Concentrations of vascular endothelial growth factor in the sera of normal controls and cancer patients. Clin. Cancer Res. 2:1996;821-826
14. Barton D.P., Cai A., Wendt K., Young M., Gamero A., De Cesare S. Angiogenic protein expression in advanced epithelial ovarian cancer. Clin. Cancer Res. 3:1997;1579-1586
15. Poon R.T.-P., Fan S.-T., Wong Y. Clinical implication of circulating angiogenic factors in cancer patients. J. Clin. Oncol. 19:2001;1207-1225
16. Fujimoto J., Sakaguchi H., Aoki I., Tamaya T. The value of platelet-derived endothelial cell growth factor as a novel predictor of advancement of uterine cervical cancers. Cancer Res. 60:2000;3662-3665
17. Muro H., Waguri-Nagaya Y., Otsuka T., Matsui N., Asai K., Kato T. Serum gliostatin levels in patients with rheumatoid factor-negative and -positive rheumatoid arthritis and changes of these levels after surgical treatments. Clin. Rheumatol. 20:2001;331-336
18. Shimada H., Takeda A., Shiratori T., Nabeya Y., Okazumi S., Matsubara H., et al. Prognostic significance of serum thymidine phosphorylase concentration in esophageal squamous cell carcinoma. Cancer. 94:2002;1947-1954
19. Katayanagi S., Aoki T., Takagi Y., Ito K., Sudo H., Tsuchida A., et al. Measurement of serum thymidine phosphorylase levels by highly sensitive enzyme-linked immunosorbent assay in gastric cancer. Oncol. Rep. 10:2003;115-119
20. Vermeulen P.B., Gasparini G., Fox S.B., Toi M., Martin L., McCelloch P., et al. Quantification of angiogenesis in solid human tumours: an International Consensus on the methodology and criteria of evaluation. Eur. J. Cancer. 32:1996;2474-2484
21. Yoshimura A., Kuwazuru Y., Furukawa T., Yoshida H., Yamada K., Akiyama S. Purification and tissue distribution of human thymidine phosphorylase; high expression in lymphocytes, reticulocytes and tumors. Biochim. Biophys. Acta. 1034:1990;107-113
22. Bradford M.A. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:1976;248-254
23. Takebayashi Y., Yamada K., Miyadera K., Sumizawa T., Furukawa T., Kinoshita F., et al. The activity and expression of thymidine phosphorylase in human solid tumours. Eur. J. Cancer. 32:1996;1227-1232
24. Miszczak-Zaborska E., Greger J., Wozniak K., Kowalska-Koprek U., Pajszczyk-Kieszkiewicz T. The activity of thymidine phosphorylase in the uterine myomas and the myometrium in perimenopausal women. Z. Naturforsch. [C]. 52:1997;850-854
25. Watanabe Y., Nakai H., Ueda H., Nozaki K., Hoshiai H., Noda K. Platelet-derived endothelial cell growth factor predicts of progression and recurrence in primary epithelial ovarian cancer. Cancer Lett. 200:2003;173-176
26. Saeki T., Takahashim S., Hosovaka S., Moriwaki S., Nagasaki K., Masaki T., et al. Differential expression of platelet-derived endothelial cell growth factor (thymidine phosphorylase) in nonpolypoid and polypoid lesions of the colon. Int. J. Oncol. 8:1996;1105-1111
27. Maeda K., Chung Y.S., Ogawa Y., Takatsuka S., Kang S.M., Ogawa M., et al. Thymidine phosphorylase/platelet-derived endothelial cell growth factor expression associated with hepatic metastasis in gastric carcinoma. Br. J. Cancer. 73:1996;884-888
28. Katayanagi S., Aoki T., Takagi Y., Ito K., Sudo H., Tsuchida A., et al. Measurement of serum thymidine phosphorylase levels by highly sensitive enzyme-linked immunosorbent assay in gastric cancer. Oncol. Rep. 10:2003;115-119
29. Shimada H., Takeda A., Shiratori T., Nabeya Y., Okazumi S., Matsubara H., et al. Prognostic significance of serum thymidine phosphorylase concentration in esophageal squamous cell carcinoma. Cancer. 94:2002;1947-1954
30. Fujimoto J., Ichigo S., Sakaguchi H., Hirose R., Tamaya T. Expression of platelet-derived endothelial cell growth factor (PD-ECGF) and its mRNA in ovarian cancers. Cancer Lett. 126:1998;83-88
31. Terai Y., Ueda M., Kumagai K., Ueki K., Ueki M. Tumor angiogenesis and thymidine phosphorylase expression in ovarian carcinomas including serous surface papillary adenocarcinoma of the peritoneum. Int. J. Gynecol. Pathol. 19:2000;354-360
32. Kuwahara K., Sasaki T., Kuwada Y., Murakami M., Yamasaki S., Chayama K. Expressions of angiogenic factors in pancreatic ductal carcinoma: a correlative study with clinicopathologic parameters and patient survival. Pancreas. 26:2003;344-349
33. Hata K., Hata T., Collins W.P. Association of thymidine phosphorylase concentration with ultrasound-derived indices of blood flow in ovarian masses. Cancer. 80:1997;1079-1084
34. Arras M., Ito W.D., Scholz D. The role of TNF in angiogenesis. Clin. Invest. 101:1998;40-43
35. Folkman J. Tumor angiogenesis and tissue factor. Nat. Med. 2:1996;167-171
36. Kubiak R., Miszczak-Zaborska E., Jesionek-Kupnicka D., Greger J.J. The activity of thymidine phosphorylase correlates with tumor size and lymph nodes status in breast carcinoma. Z. Naturforsch. [C]. 54:1999;1096-1102
37. Stȩpień H.M., Kolomecka K., Pasieka Z. Angiogenesis of endocrine gland tumors-new molecular targets in diagnostic and therapy. Eur. J. Endocrinol. 146:2002;143-151
38. Stevenson D.P., Milligan S.R., Collins W.P. Effects of platelet-derived endothelial cell growth factor/thymidine phosphorylase, substrate, and products in a three-dimensional model of angiogenesis. Am. J. Pathol. 152:1998;1641-1646
39. Hata K., Fujiwaki R., Maeda Y., Nakayama K., Fukumoto M., Miyazaki K. Expression of thymidine phosphorylase in epithelial ovarian cancer: correlation with angiogenesis, apoptosis, and ultrasound-derived peak systolic velocity. Gynecol. Oncol. 77:2000;26-34
40. Hata K., Yoshida M., Maruyama R., Fujiwaki R., Miyazaki K. Prognostic significance of ultrasound derived intratumoral peak systolic velocity in epithelial ovarian cancer. Ultrasound Obstet. Gynecol. 20:2002;186-191
41. Fox S.B., Westwood M., Moghaddam A., Compley M., Turley H., Whitehouse R.M., et al. The angiogenic factor platelet-derived endothelial cell growth factor/thymidine phosphorylase is up-regulated in breast epithelium and endothelium. Br. J. Cancer. 73:1996;275-280
42. Zhang J., Mizoi T., Harada N., Shiiba K., Miyagawa K., Matsuno S., et al. Thymidine phosphorylase expressed in macrophages enhances antitumor effect of 5′-deoxy-5-fluorouridine on human colorectal carcinoma cells. Anticancer Res. 23:2003;323-329
43. Takahashi Y., Bucana C.D., Akagi Y., Liu W., Cleary K.R., Mai M., et al. Significance of platelet-derived endothelial cell growth factor in the angiogenesis of human gastric cancer. Clin. Cancer Res. 4:1998;429-434
44. Sugiyama A., Maruta F., Tsuzuki S., Murakami M., Kawasaki S. Distribution of thymidine phosphorylase activity in gastric carcinoma and adjacent normal gastric tissue. Hepatogastroenterology. 49:2002;1734-1736